Proteon Therapeutics

Boston, MA

CEO: Timothy Noyes


Proteon Therapeutics is a biotechnology company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with renal and vascular diseases. The company is leveraging a unique understanding of tissue remodeling to develop a pipeline of proprietary therapeutics, with an initial clinical focus on vascular access for hemodialysis and peripheral arterial disease (PAD).